Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

First Quarter Trading Statement

28 Apr 2011 07:00

RNS Number : 5748F
Croda International PLC
28 April 2011
 



28 April 2011

 

 

Croda International Plc

First quarter trading statement

 

Martin Flower, Chairman of Croda International Plc, is due to provide the following update on first quarter trading for the period ended 31 March 2011 at today's Annual General Meeting:

 

"I am pleased to report a strong start to 2011 with record sales and profits in both Consumer Care and Industrial Specialities with robust demand continuing across all major geographies.

 

Group sales increased 13.2% to £277.9m (2010: £245.5m) despite adverse currency translation of 2.4%. Overall volumes were slightly down as we continue to reposition our Industrial Specialities operations away from lower price/higher volume products towards more speciality business. Average prices rose during the quarter as we passed on significant raw material cost increases into the market. We have implemented further price increases where necessary in April.

 

Group pre-tax profit from continuing operations increased 40.2% to £60.7m (2010: £43.3m).

 

On a segmental basis, Consumer Care operating profit was up 22.2% to £42.4m (2010: £34.7m) with Personal Care, Health Care and Crop Care all seeing significant sales and profit growth.

 

Industrial Specialities again achieved extremely robust profit growth of 63.7% to £18.5m (2010: £11.3m) despite the volume decline described above and adverse currency movements.

 

Net debt reduced by £5.3m since the year-end to £215.1m despite an unfavourable currency movement of £1.5m.

 

We are pleased with the performance to date and are confident of reporting further progress throughout 2011."

 

 

 

 

For further information, please contact:

 

Mike Humphrey, Group Chief Executive

Tel: 01405 860551

Sean Christie, Group Finance Director

Hazel Stevenson, Financial Dynamics

Tel: 0207 269 7176

 

 

The company will host a conference call for analysts at 8.00am (BST) today:

Dial-In: +44 (0)1452 542 304

Please quote "Croda International"to gain access to the call

 

 

Croda International Plc

Unaudited income statement before tax and exceptional items

31 March 2011

£m

3 months to

3 months to

31 March

31 March

2011

2010

Change

Consumer Care

146.3

128.1

+14.2%

Industrial Specialities

131.6

117.4

+12.1%

Revenues from continuing operations

277.9

245.5

+13.2%

Consumer Care

42.4

34.7

+22.2%

Industrial Specialities

18.5

11.3

+63.7%

Operating profit from continuing operations

60.9

46.0

+32.4%

Net bank and loan interest payable

(2.0)

(2.8)

Net retirement benefit scheme financing

1.8

0.1

Profit before tax from continuing operations

60.7

43.3

+40.2%

Operating margin

21.9%

18.7%

Analysis of turnover uplift for continuing operations

Volume

-0.5%

Currency impact

-2.4%

Price/mix

+16.1%

+13.2%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIRMATMBJTBJB
Date   Source Headline
2nd Jun 20213:38 pmRNSCroda completes acquisition of Parfex
21st May 20214:06 pmRNSResult of AGM
18th May 20212:01 pmRNSDirector/PDMR Shareholding
11th May 20212:57 pmRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSStrategic review of PT&IC businesses
30th Apr 20213:44 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:17 amRNSDirector Declaration
14th Apr 20215:13 pmRNSDirector/PDMR Shareholding
13th Apr 20212:41 pmRNSDirector/PDMR Shareholding
12th Apr 202110:34 amRNSDirector/PDMR Shareholding
9th Apr 20215:51 pmRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSCroda acquires fragrance business Parfex
6th Apr 20216:06 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
30th Mar 20215:13 pmRNSDirector/PDMR Shareholding
25th Mar 202111:11 amRNSWebinar launch Croda’s Sustainability Report 2020
25th Mar 202110:55 amRNSAnnual Financial Report
24th Mar 20213:12 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:07 amRNSDirector/PDMR Shareholding
22nd Mar 202111:54 amRNSDirector/PDMR Shareholding
17th Mar 20214:37 pmRNSDirector/PDMR Shareholding
17th Mar 20214:35 pmRNSDirector/PDMR Shareholding
17th Mar 20214:32 pmRNSDirector/PDMR Shareholding
17th Mar 20214:31 pmRNSDirector/PDMR Shareholding
17th Mar 20214:30 pmRNSDirector/PDMR Shareholding
17th Mar 20214:29 pmRNSDirector/PDMR Shareholding
17th Mar 20214:28 pmRNSDirector/PDMR Shareholding
17th Mar 20214:27 pmRNSDirector/PDMR Shareholding
17th Mar 20214:23 pmRNSDirector/PDMR Shareholding
17th Mar 20214:23 pmRNSDirector/PDMR Shareholding
17th Mar 20214:22 pmRNSDirector/PDMR Shareholding
17th Mar 20214:19 pmRNSDirector/PDMR Shareholding
11th Mar 20213:25 pmRNSDirector/PDMR Shareholding
2nd Mar 20217:02 amRNSCroda acquires Alban Muller
2nd Mar 20217:00 amRNSFinal Results
11th Feb 20213:12 pmRNSDirector/PDMR Shareholding
12th Jan 20215:26 pmRNSDirector/PDMR Shareholding
30th Dec 20205:07 pmRNSDirector/PDMR Shareholding
11th Dec 20203:33 pmRNSDirector/PDMR Shareholding
30th Nov 20208:57 amRNSTotal Voting Rights
24th Nov 202012:52 pmRNSCroda completes acquisition of Iberchem
24th Nov 202010:39 amRNSDirector/PDMR Shareholding
24th Nov 202010:38 amRNSDirector/PDMR Shareholding
18th Nov 20205:30 pmRNSCroda International
18th Nov 20203:54 pmRNSResults of the Placing
18th Nov 20207:01 amRNSRetail Offer via PrimaryBid.com
18th Nov 20207:00 amRNSAcquisition of Iberchem
11th Nov 20204:50 pmRNSDirector/PDMR Shareholding
10th Nov 20201:41 pmRNSCOVID-19 vaccine contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.